<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30142017</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1532-4192</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>36</Volume>                    <Issue>7</Issue>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Cancer investigation</Title>                <ISOAbbreviation>Cancer Invest.</ISOAbbreviation>            </Journal>            <ArticleTitle>Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>378-388</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1080/07357907.2018.1499934</ELocationID>            <Abstract>                <AbstractText>BRCA-1 mutation-associated triple-negative breast cancer (TNBC) has been hypothesized to exhibit a phenotype that is distinct from non-mutation carriers. We have analyzed immunohistochemically detected cytokeratins 5 and 14, epidermal growth factor receptor (EGFR), claudin (CLDN) 3, 4, and 7, and E-cadherin in 57 TNBC (32 BRCA1 and 8 BRCA2 tumors, 17 WT tumors). Positive staining of CLDN3 and negative EGFR expression in TNBC are associated with a BRCA1 mutation. EGFR and CLDN3 expression was able to predict the presence of BRCA1 mutation (area under curve 0.802, p &lt; 0.001). This could help in guiding the decision for BRCA testing.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Danzinger</LastName>                    <ForeName>Sabine</ForeName>                    <Initials>S</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4316-6399</Identifier>                    <AffiliationInfo>                        <Affiliation>a Department of Obstetrics and Gynecology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tan</LastName>                    <ForeName>Yen Yen</ForeName>                    <Initials>YY</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1063-5352</Identifier>                    <AffiliationInfo>                        <Affiliation>a Department of Obstetrics and Gynecology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rudas</LastName>                    <ForeName>Margaretha</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>b Department of Pathology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kastner</LastName>                    <ForeName>Marie-Theres</ForeName>                    <Initials>MT</Initials>                    <AffiliationInfo>                        <Affiliation>a Department of Obstetrics and Gynecology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weingartshofer</LastName>                    <ForeName>Sigrid</ForeName>                    <Initials>S</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2967-6621</Identifier>                    <AffiliationInfo>                        <Affiliation>a Department of Obstetrics and Gynecology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Muhr</LastName>                    <ForeName>Daniela</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>a Department of Obstetrics and Gynecology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Singer</LastName>                    <ForeName>Christian F</ForeName>                    <Initials>CF</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1294-0027</Identifier>                    <AffiliationInfo>                        <Affiliation>a Department of Obstetrics and Gynecology , Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>kConFab Investigators</CollectiveName>                    <AffiliationInfo>                        <Affiliation>c Kathleen Cuningham Foundation Consortium for research into Familial Breast cancer, Peter MacCallum Cancer Centre , Parkville , Australia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Cancer Invest</MedlineTA>            <NlmUniqueID>8307154</NlmUniqueID>            <ISSNLinking>0735-7907</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D019313">BRCA1 Protein</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C492913">BRCA1 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C568122">CLDN3 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D062465">Claudin-3</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="C512478">EGFR protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D011958">Receptor, Epidermal Growth Factor</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019313" MajorTopicYN="N">BRCA1 Protein</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014408" MajorTopicYN="Y">Biomarkers, Tumor</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D062465" MajorTopicYN="N">Claudin-3</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011958" MajorTopicYN="N">Receptor, Epidermal Growth Factor</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D064726" MajorTopicYN="N">Triple Negative Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">BRCA1</Keyword>            <Keyword MajorTopicYN="N">BRCA2</Keyword>            <Keyword MajorTopicYN="N">Claudin 3</Keyword>            <Keyword MajorTopicYN="N">Epidermal growth factor receptor</Keyword>            <Keyword MajorTopicYN="N">Immunohistochemistry</Keyword>            <Keyword MajorTopicYN="N">Triple-negative breast cancer</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30142017</ArticleId>            <ArticleId IdType="doi">10.1080/07357907.2018.1499934</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>